XSES
AP4
Market cap969mUSD
Jul 10, Last price
0.86SGD
1D
1.18%
1Q
8.92%
Jan 2017
94.32%
IPO
1,194.47%
Name
Riverstone Holdings Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Riverstone Holdings Limited, an investment holding company, primarily manufactures and distributes gloves for both cleanroom and healthcare applications from its base in Malaysia. Its extensive cleanroom product line encompasses finger cots, static-shielding and packaging bags, face masks, and wipers. The company also offers a wide array of other consumables, including hairnets, antistatic gloves, conductive latex finger cots, static-dissipative footwear (shoes, safety booties, and shoe covers), cleanroom coveralls, ESD rubber bands, sticky mats and rollers, polyester and microfiber swabs, and specialized cleanroom papers. For the healthcare sector, Riverstone provides various medical products, notably nitrile examination gloves in blue, white, black, and accelerator-free options. In addition to its manufacturing activities, the company trades in latex products and distributes cleanroom supplies. These offerings are sold under the RS brand and are utilized across the hard disk drive, semiconductor, and healthcare industries. With a global presence, Riverstone exports its products to Asia, Europe, and the Americas. Founded in 1989, Riverstone Holdings Limited is headquartered in Singapore and operates as a subsidiary of Raffles Nominees (PTE.) Limited.
Valuation
Title MYR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||